glm tirzepatide Compounded (GLP-1/GIP) Pharmacogenomics of Tirzepatide: Genomic Insights

GLP-1 therapies and personalized plans to help you lose weight and keep it off

Wegovy pill: first oral GLP-1 approved for weight loss In a landmark development, the FDA approved the Wegovy pill (oral semaglutide 25 mg) on December 22, 2025 , making it the worlds first oral GLP-1 receptor agonist approved specifically for weight management a major shift from the injection-only landscape [8]

Sublingual drops are placed under the tongue once daily, where the medication absorbs through the oral mucosa into the bloodstream

Concerns Over Dosing and Purity : Lilly argues that compounding tirzepatide may lead to significant dosing inconsistencies, as compounded versions may not achieve the exact potency and purity required

Some Dihexa creams may also contain other beneficial ingredients for the skin, such as moisturizers, vitamins, etc